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Abstract 
Background 
The Annual Health Check (AHC) program, as part of a Directed Enhanced Service (DES), 
offers an incentive to general practitioners (GPs) in England to conduct health checks for 
people with intellectual disabilities (IDs). The aim of this analysis was to estimate the impact 
on healthcare costs of AHCs in primary care to the NHS in England by comparing adults with 
ID who did or did not have AHCs using data obtained from The Health Improvement Network 
(THIN).  
Methods 
Two hundred and eight records of people with ID from THIN database were analysed. Baseline 
healthcare resource use was captured at the time the first AHC was recorded (i.e., index date), 
or the earliest date after 1st of April 2008 for those without an AHC. We examined the volume 
of resource use and associated costs that occurred at the time AHCs were performed, as well 
as before and after the index date. We then estimated the impact of AHCs on healthcare costs. 
Results 
The average cost of AHC was estimated at £142.57 (95%CI £135.41 to £149.74). Primary, 
community and secondary healthcare costs increased significantly after the index date in the 
no AHC group due to higher increase in resource utilisation. Regression analysis showed that 
the expected healthcare cost for those who have an AHC is 56% higher than for those who did 
not have an AHC. Age and gender were also associated with increase in expected healthcare 
cost.  
Conclusion 
The level of resource utilisation increased in both (AHC and no AHC) groups after the index 
date. Although the level of resource use before index date was lower in the no AHC group, it 
increased after the index date up to almost reaching the level of resource utilisation in the AHC 
group. Further research is needed to explore if the AHCs are effective in reducing health 
inequalities.  
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Introduction 
An increasing proportion of the people with intellectual disability (ID) lives in the community 
and often has associated health issues, such as cardiovascular, respiratory, gastrointestinal, 
endocrine, mental health problems, and epilepsy (Cooper et al. 2007; Emerson et al. 2013).  
People with ID are less likely to access routine health checks, which may be a result of needing 
to rely on their family/carers to attend general practitioner (GP) appointments (Alborz et al. 
2005). Therefore, appropriate healthcare is essential for this population given the high 
morbidity burden, and the early intervention of their GP is therefore very important to their 
overall health (Emerson & Baines 2010). In the UK, the GP is the main primary health care 
provider of health care for people with ID. Implementation of a management plan, compliance 
and continuity of care for people with ID could help the identification of important 
comorbidities, which might lead to a reduction in avoidable health issues and deaths if 
effectively managed. 
The National Health Service (NHS) England introduced the Annual Health Check (AHC) 
program for people with ID in 2008/2009 as a Directed Enhanced Service (DES) in primary 
care. This enhanced service  is designed to encourage GP practices to identify all patients aged 
14 and over with ID, to maintain a ID 'health check' register and offer them AHCs, which will 
include producing a health action plan (The NHS Confederation (Employers) 2012). AHCs for 
people with ID are designed to improve their health by identifying unmet needs, potentially 
treatable conditions, and timely access to further care.  The approximate number of those with 
ID and significant impairment in functional abilities known to service providers in England 
and thus eligible for AHCs was estimated to be over 214,000 in 2013/2014 (Hatton et al. 2016). 
The Royal College of General Practitioners (RCGP) produced guidelines that GPs should carry 
out AHCs for all people with an ID (RCGP 2010). This recommends that all health checks 
include an assessment of feeding, bowel and bladder functions, assessment of behavioural 
disturbance and assessment of vision and hearing. There are also some syndrome-specific 
checks that GPs should carry out for people with specific conditions associated with particular 
physical health problems, such as in people with Down syndrome. In 2012/2013, 52% of 
eligible people with IDs received an AHC (Glover & Niggebrugge 2013). 
It has been shown that people with ID from general practices that had enrolled in the AHC 
program were offered significantly more general health measurements, blood tests, and specific 
health screening compared to general practices that had not enrolled in the program, and 
identification rates for previously un-identified health problems were also higher (Buszewicz 
et al. 2014). 
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Undertaking comprehensive AHCs may however require considerable effort in terms of 
resource use which will be associated with costs within primary healthcare services. Health 
checks were estimated to cost the NHS £60.7 million over 3 years based on estimates of 
associated activity, costs and uptake by general practices (DoH 2009).  
There is limited published literature quantifying the cost impact of AHCs in people with IDs 
and, for those existing, the setting, population and methodology used make comparison across 
the studies difficult. A study conducted in Greater Glasgow Health Board area, Scotland, in 
100 people with ID (50 of whom received an AHC) around the time of the introduction of 
AHCs in England suggested that there were no increased costs in terms of service use, and 
concluded that AHCs are relatively inexpensive (mean cost per person estimated at £82) and 
do not have significant service implications (Romeo et al. 2009). 
In addition, a study conducted in Australia (Gordon et al. 2012)  showed no significant 
differences in healthcare costs over 12 months between people with ID who received health 
assessments compared with people who did not receive health assessments (AUD 4523 vs. 
AUD 4466). The authors concluded that health assessments led to significantly increased health 
promotion, but overall created a neutral impact on costs, while at the same time the assessment 
encouraged more targeted patient services. 
The aim of this analysis was to estimate the resource use and the impact on healthcare costs of 
AHCs in primary care to the NHS in England by comparing adults with ID who did or did not 
have AHCs using data obtained from The Health Improvement Network (THIN). This included 
the cost of the AHC, as well as investigating whether the AHCs generated additional costs to 
the NHS by identifying additional medical care needed.  
Methods 
Data source and study population 
The THIN research database is a longitudinal primary care database of over 12 million 
anonymised primary care medical records collected from 587 general practices in the UK, 
covering 5.7% of the UK population in 2014. THIN data are representative for the UK 
population (IMS Health RWES 2016).  
The THIN database contains diagnostic and prescribing information recorded by GPs who have 
opted into the data recording scheme as part of their routine clinical practice and it is used 
extensively for research purposes. Data are recorded using coded clinical language (Read codes 
[Chisholm 1990]), which consist of a hierarchically arranged comprehensive list of clinical 
terms to describe the healthcare of patients in general practice, and encrypted identification 
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codes from the UK Prescription Pricing Authority (Joint Formulary Committee 2013) 
classified according to the British National Formulary (BNF) for prescriptions.  
The data for this study were extracted from a larger study (Buszewicz et al. 2014) which 
investigated whether the AHC program had improved healthcare for people with ID using data 
from the THIN research database. English general medical practices were included if, before 
1st of January 2009, the average annual recording rates were at least one medical record, one 
additional health data record, and two prescription records per person per year across the whole 
practice population, and practice mortality recording rates were similar to general UK 
population mortality after accounting for the distributions of age and sex. Eligible persons were 
aged at least 18 years and had known ID identified with specific Read codes used to include 
them in the practice Quality and Outcomes Framework (QOF) register.  The QOF is a system 
for the performance management and payment of GPs in the NHS in England, Wales, Scotland 
and Northern Ireland. It was introduced as part of the new general medical services (GMS) 
contract in April 2004, replacing various other fee arrangements. GP practices are entitled to a 
payment of £140 (value from April 2017) in any one financial year for each patient aged 14 or 
over on the GP practices agreed ID register who received an AHC (The NHS Confederation 
(Employers) (2018). In the program there were 8692 people with ID in 222 incentivised general 
practices and 918 people with ID in 48 non-incentivised general practices. For our study, we 
selected 208 medical records from 12 incentivised general practices ensuring that the practices 
selected covered the full range of social deprivation and different regions. One hundred and 
two medical records had no entry for an AHC and 106 medical records had at least one entry 
for AHC. Baseline healthcare resource use was captured at the time of the first AHC (i.e., index 
date). For people who had no entries for an AHC, we used the earliest date that they could have 
had an AHC after 1st of April 2008 as their index date. Any access to healthcare was extracted 
retrospectively for the period of time from the index date until the latest date possible that a 
contact could be recorded: 31st of December 2011.  
Healthcare resource use  
Annual Health Check 
When identifying relevant Read codes, we used those recommended by the guideline produced 
to help GPs and practice nurses to organise and perform high quality AHCs in people with ID: 
weight, height, blood pressure measurement; blood, urine analysis; smoking, alcohol and 
illegal drugs status; vision, hearing, communication and mobility assessment; 
immunisation/vaccination status; cervical screening and mammography status; chronic 
illnesses enquiry; sexual health enquiry; behavioural changes; medication review and 
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prescriptions; proposed health action plan and syndrome specific medical health checks (RCGP 
2010).  
Primary care services 
Read codes were used to estimate the number of primary healthcare professional contacts 
before and after the index date, and any other resources accessed. The mean number of primary 
healthcare contacts was calculated as the sum of all recorded contacts within primary care. 
Contacts with primary healthcare professionals were classified into the following categories: 
GP visits (at general practice/home or phone consultation); practice nurse visits (at general 
practice/home or phone consultation), and community nurse visits (at general practice or 
clinic/home or phone consultation).  
Secondary care services 
The mean number of referrals to secondary care services, laboratory, and imaging and other 
outpatient services, accident and emergency services were calculated. Secondary care is 
captured in THIN via Read codes either when a person is referred to a secondary care service, 
or they have an unplanned contact with a secondary care service and a letter is sent to their GP. 
As the database does not directly capture secondary care service use (only a limited number of 
general practices are linked to the Hospital Episode Statistics (HES)), some of the data on 
secondary care services may be incomplete. Hence, we made the following assumptions to 
estimate secondary care services utilisation: for data recorded on THIN about any type of 
hospitalisation, the length of stay was calculated by subtracting the admission date from the 
discharge date from the information recorded within the study period.  Where this information 
was not available, we used the mean length of stay (DoH 2015) for the condition/procedures 
for which people with ID were hospitalised. Outpatient appointments were accounted for if a 
referral to an outpatient service was not followed by an entry of “did not attend” or if there was 
evidence of recording of outcomes of an outpatient contact in the GP records.  
Prescriptions 
All recorded prescriptions were aggregated for each person, with the number of individual 
doses prescribed before and after the index date. Net ingredient costs per dose, based on the 
September 2014 edition of the BNF were applied to the doses recorded, in order to arrive at a 
total cost of prescriptions issued.  
Healthcare resource costs 
Costs were estimated by multiplying the number of units used for each relevant resource factor 
obtained from the THIN database with the corresponding unit cost (Online Supplementary 
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Table 1). Total costs were measured as average yearly costs by adding up the total primary and 
secondary care costs, inpatient care costs, outpatient care costs, and prescription costs.  
Based on providing evidence of completed AHCs, general practices receive payment under the 
DES on a quarterly basis calculated from the number of completed AHCs for people with ID 
undertaken in the previous quarter. Accordingly, we included this payment (£100 per health 
check at the time we conducted the study) for those who had undergone first AHC in this study 
((The NHS Confederation (Employers) (2012)). Where multiple AHCs following the index 
date AHC were recorded, we considered them as GP visits. 
Resource use costs were calculated using cost references from the NHS national schedule of 
reference costs (DoH 2015) and the Personal Social Services Research Unit (PSSRU) (Curtis 
2014). Costs were calculated in 2013/14 UK pounds (£). 
Statistical methods 
Summaries are presented as means and standard deviations (SD) for continuous outcomes and 
numbers and percentages (%) for categorical outcomes. The outcomes of interests were the 
mean number of different types of person-level health services resource utilisation and their 
associated costs before and after the index date in both (AHC and no AHC) groups. The 
resource utilisation and associated costs before and after the index date for each group was 
compared using t-tests. We considered the statistical significance to be at the 5% level. 
We then examined factors associated with healthcare costs using negative binomial regression 
(Cameron & Trivedi 2013), including: the length of time before and after the index date 
(exposure duration) differed between individual persons, and in particular between the AHC 
(mean 1.85 years) and the no AHC (mean 3.75 years) groups. The difference between the two 
groups was predominately because we chose the “earliest possible time point they could have 
received an AHC” as the index date for the no AHC group; a problem with this is that longer 
periods of time would likely have been associated with higher number of resource use, and 
shorter periods of time would likewise be likely to have lower number for resource use. Given 
that failure to account for variability in exposure duration could bias the regression results, we 
included exposure duration for each person in the regression analysis to account for the 
potential number of times the event could have happened (Atkins et al. 2013).  
The influence of AHC on each individual’s healthcare costs was analysed using the negative 
binomial regression model, adjusting for age and gender, with the total healthcare cost after the 
index date as response variable, the exposure duration as the offset, and the AHC, age, gender 
and costs before the index date as explanatory variables. Results are presented as incident rate 
ratios. We would have attempted to control for severity of the ID, but a large amount of medical 
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records (>65% in each group) did not have a clear entry for the severity of ID. Analyses were 
performed using STATA version 14.1 (StataCorp. 2014).  
Results 
Demographic characteristics 
The medical records of identified people with ID (n=208; 106 with AHC and 102 with no 
AHC) came from 12 incentivised general practices. The number of medical records per general 
practice ranged from 7 to 36. The groups were fairly well balanced in terms of age and gender. 
Severity of ID was poorly recorded in both groups. There was an uneven geographical 
representation; more medical records in the no AHC group were from the South East Coast 
whereas more medical records in the AHC group were from London. Demographic 
characteristics are presented in Table 1. 
Annual Health Check routine assessments  
The mean number (SD) of routine assessments performed during an AHC was 8.83 (4.27) and 
they were conducted by either practice nurses (48% of the AHCs) or GPs (44% of the AHCs). 
The mean number of routine assessments per AHC was similar whether they were conducted 
by practice nurses (9.63; SD 4.00) or GPs (9.34; SD 3.71). There were people with ID who had 
more than one AHC during the study period. Weight, blood pressure measurements, alcohol 
status, mobility, hearing and vision assessments and dental examinations were performed and 
a Health Action Plan was offered at more than 50% of the AHC visits. Other routine assessment 
included: basic assessment of behaviour and communication, “other medical” (as they were 
recorded) assessments, smoking status recording, weight monitoring, medication review, 
health education, and referral for laboratory tests. There was a mean (SD) of 2.18 (2.50) 
prescriptions issued per AHC visit; 32% of people with ID received prescriptions for central 
nervous system problems, followed by 18% for cardiovascular system problems. Other 
prescriptions were issued for skin, respiratory system, gastrointestinal system, and endocrine 
system problems (see Table 2). 
Healthcare resource use and costs 
There were statistically significant increases in mean number of contacts with GPs (1.59; 
p=0.033), practice nurses (0.51; p=0.015), and community nurses (0.08; p=0.018), in the no 
AHC group after the index date. Statistically significant increases in primary care resource use 
in the AHC group after the index date were observed in the mean number of GP phone contacts 
(0.46; p=0.014) (see Table 3).  
People in the no AHC group had a significant increase in the mean number of unplanned 
admissions (admissions with no referral letter) (0.06; p=0.018), and contacts with community 
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healthcare services (0.15; p=0.044), as well as outpatient contacts (0.59; p=0.002).  The only 
statistically significant increase in the AHC group was in the mean number of outpatient 
contacts (1.15; p=0.001) (see Table 3).  
The mean number of prescriptions for immune system agents (0.09; p=0.013) increased 
significantly in the AHC group after the index date (see Table 3).  
To note is that for both groups the level of resource utilisation increased after the index date. 
Although the level of resource utilisation before the index date was lower in the no AHC group 
than in the AHC group, it increased after the index date almost reaching the level of resource 
utilisation in the AHC group. 
The average cost of an AHC was estimated at £142.57 (95%CI £135.41 to £149.74). 
There was statistically significant increase in costs for primary care contacts (£96.43; p=0.020) 
and community and secondary care activities (£157.79; p=0.008) in the no AHC group after 
the index date (see Table 4).   
Differences in total costs before and after the index date was not statistically significant in any 
of the groups; in the no AHC group this difference was double that of the AHC group due to a 
higher increase in resource utilisation after the index date. Even so, the total cost in the AHC 
group remained higher than in the no AHC group. 
The results of the negative binomial regression analysis are detailed in Table 5. Holding other 
regressors and the standard error constant, the expected healthcare cost for those who have an 
AHC is 56% higher than for those who did not have an AHC. Similarly, the expected healthcare 
cost for females was 55% higher than for males. For each additional year of age, the expected 
healthcare cost is increased by 1.6%.  
Discussion 
This study analysed the impact of the AHC scheme specifically targeting people with ID in the 
community setting using the THIN dataset. Based on an in-depth review of healthcare activity 
following AHCs, our study is more reflective of what happens in “real-life”. The study shows 
that AHCs had a good coverage of general and specific health assessments of people with ID, 
which has previously been shown to lead to an increased likelihood of identifying new 
comorbidities such as gastrointestinal and thyroid disorders, constipation, and being 
underweight or obese (Buszewicz et al. 2014). 
In general, resource utilisation was lower in the no AHC group than in the AHC group before 
the index date; however the resource utilisation increased in both groups after the index date. 
To note is that the levels of resource utilisation in the no AHC group increased after the index 
date, almost reaching the levels of those in the AHC group. We observed a significant increase 
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in contacts with GPs, practice nurses, and community nurses and healthcare services, as well 
as in outpatient appointments and unplanned hospital admissions for the people that did not 
receive an AHC. For people that did receive an AHC there was significant increase in GP phone 
consultations, and outpatient appointments. Hence, we found that the burden of healthcare 
resources was higher after the index date in both groups, yet significant increases in 
primary/community and secondary care resources utilisation were noted predominantly in 
resource use associated with unplanned health care attendances in the no AHC group, whereas 
this same pattern was not seen in the AHC group.  This suggests that AHCs may have helped 
to identify and manage the type of problems that might otherwise lead to unplanned healthcare 
resource use.  
Our study cannot reveal why people with ID registered with an incentivised general practice 
did not receive an AHC.  A previous study (Buszewicz et al. 2014) showed that Read codes 
identifying that people with ID had been invited to attend a health check were infrequently 
used, and most general practices only recorded completion of incentivised health checks.  
Our study also cannot reveal why people with ID in the no AHC group were seeking 
significantly more primary/community and secondary care and had more prescriptions for 
central nervous system after the index date and further research on this is required. It could be 
that people with more complex health needs (e.g., more severe ID) are more likely to get more 
healthcare. However, we were unable to conclude that severity of ID potentially increased 
healthcare resource utilisation due to the fact that the severity of people’s ID was seldom 
recorded in our sample.  
People with ID are some of the highest consumers of medications (e.g., psychotropic and anti-
epileptic) with high rates of potentially serious side-effects (de Kuijper et al. 2010). Our study 
was unable to conclude that the higher numbers of prescriptions for cardiovascular, central 
nervous and gastrointestinal problems in the AHC group was driven by the severity of the 
people’s ID or other reasons.  However, the number of prescriptions in the AHC group 
appeared to go down slightly after the index date, as well as the associated costs, which may 
be due to active health promotion strategies around diet and exercise put in place during the 
AHCs to avoid potential significant interactions. 
Although AHCs result in  increased expected costs mainly due to referrals to other services, 
they appeared  to result in better health monitoring and more preventive care (e.g. 
immunisations), which may be associated with a reduction in unexpected visits and non-
elective admissions, and possibly reduced mortality rate. AHCs therefore seem to be effective 
in reducing health inequalities as intended, although further work to determine the medium to 
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long term impact of AHCs on outcomes, their long-term costs, and any financial gains from 
conducting AHCs is needed (Cooper et al. 2014). 
Strengths and limitations 
This is the first study to explore the costs associated with healthcare provision to people with 
ID using a tool such as the THIN research database.  However, the results presented here are 
different from those reported in another UK study (Romeo et al. 2009) where the mean cost of 
AHCs (£82) was lower than in our study (£143). This may be because we included the general 
practice reimbursement of £100 per person for completed first AHC. Another explanation 
could be that in the former study, AHCs were performed by practice nurses, whereas in our 
study, we found that in 44% of the cases, AHCs were performed by GPs who were costed at a 
higher rate than practice nurses in our analysis.   
One limitation could be that the sample size was too small and therefore this study is possibly 
underpowered to detect differences in healthcare costs between the AHC and no AHC groups.  
We conducted a number of statistical tests of changes in health care use before and after the 
index date and hence some of the significant findings may be by chance. However, although 
the sample size was small, the longitudinal nature of the dataset, with a mean follow-up of 1.85 
years (AHC group) and 3.75 years (no AHC group), generated a rich source of information.   
Given that severity of ID is sometimes associated with poorer health, it would have been helpful 
to adjust for severity of ID in the analysis as this may have accounted for some of the findings. 
However, over 65% of the medical records in both groups gave no clear indication of the 
severity of the people’s ID and we were therefore unable to adjust for severity of ID in our 
analysis. 
An additional weakness of the study is that we have only included information on healthcare 
resource use and costs. Improved care as a result of AHCs may also have a positive impact on 
quality of life, morbidity, and mortality. Morbidity changes may have been captured indirectly 
through unplanned healthcare attendances, but we had no information available on quality of 
life and the sample size and follow-up was not sufficient to assess mortality. The wider 
potential benefits of AHC should be examined these factors further as part of future research.   
This analysis was heavily reliant on the accuracy of recording of resource use in Read codes 
and there may be differences between staff in the quality of Read code recording. In particular, 
the THIN database only captures secondary care services based on letters sent from secondary 
care services to practices, and only a limited number of general practices are linked to the 
Hospital Episode Statistics (HES). Recorded data and assumptions for non-available data were 
used to inform our assessments of outpatient visits and the length of inpatient care for any type 
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of intervention detected in the medical records. As a result there may be some missing data, 
either because of letters not sent to practices about secondary care access or letters not coded 
in Read codes. Therefore, we may have underestimated the costs associated with 
hospitalisation as well as the cost of outpatient appointments. We were also unable to comment 
on the quality or overall content of the entries recorded in people’s medical files. 
Although these data were collected from the period of 2008-2011 and may not reflect the 
current practice in healthcare provided for people with ID, it does serve as feasibility study 
upon which other studies could be modeled. In addition, as this is an observational study the 
results could have been influenced by unobserved confounding factors contributing to the 
healthcare costs. Gathering data on patient services from government databases can also be a 
more efficient way to conduct economic evaluations of services than conducting full scale 
randomised control trials (Franklin et al. 2017).  
Conclusion 
People with ID that did not have an AHC had a significant increase in unplanned health care 
use that was not seen in people with AHCs. This suggests that AHCs may have led to more 
proactive management of health care for people with ID, although AHCs delivered in primary 
care for people with ID overall led to higher costs. Further research is needed to detect whether 
an AHC for people with ID translates into improved outcomes, reduced mortality, and better 
quality of life which may justify the additional cost. Also, our work showed that the analysis 
of THIN database is feasible and therefore could support a funding application to collect and 
use a larger sample.  
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Table 1. Summary of the sample 
 No Annual Health Check 
N=102 
Annual Health Check 
N=106 
Mean (SD) or N (%) Mean (SD) or N (%) 
Age (years)   
Mean (SD) 39.06 (16.27) 42.13 (16.32) 
Gender    
Male 62 (61%) 54 (51%) 
Severity of ID    
Mild 27 (26%) 15 (14%) 
Mild/moderate 7 (7%) 12 (11%) 
Moderate 2 (2%) 3 (3%) 
Severe - 1 (1%) 
Unclear 57 (56%) 68 (64%) 
Missing 9 (9%) 7 (7%) 
Strategic Health Authority   
London 11 (11%) 36 (34%) 
North West 2 (2%) 19 (18%) 
South Central - 7 (7%) 
South East Coast 66 (65%) 14 (13%) 
South West 22 (22%) 24 (23%) 
West Midlands 1 (1%) 6 (6%) 
Social deprivation   
1 (least deprived) 13 (13%) 13 (12%) 
2 12 (12%) 20 (19%) 
3 19 (19%) 30 (28%) 
4 28 (27%) 19 (18%) 
5 (most deprived) 30 (29%) 24 (23%) 
Abbreviations: SD=standard deviation; N=number; ID=intellectual disability 
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Table 2. Annual Health Check routine assessments 
Resources Mean (SD) or N (%) 
More than one AHC   
2 AHCs 61 (58%) 
3 AHCs 14 (13%) 
4 AHCs 2 (2%) 
Mean routine assessments per AHC 8.83 (4.27) 
Routine assessments conducted by   
Practice nurse  51 (48%) 
GP 47 (44%) 
Other healthcare professionals 8 (8%) 
Mean number of  AHC routine assessments undertaken by 
healthcare professionals 
 
Practice nurse 9.63 (4.00) 
GP 9.34 (3.71) 
Other healthcare professionals 4.25 (3.58) 
AHC routine assessments  
Weight measurement 85 (80%) 
Blood pressure measurement 84 (79%) 
Alcohol status 77 (73%) 
Hearing assessment 73 (69%) 
Dental examination 65 (61%) 
Mobility assessment 65 (61%) 
Vision assessment 61 (58%) 
Learning disability Health Action Plan 55 (52%) 
Behaviour assessment 50 (47%) 
Smoking status 49 (46%) 
Other medical assessment 43 (41%) 
Communication assessment 42 (40%) 
Weight monitoring 39 (37%) 
Laboratory tests referrals 29 (27%) 
Health education 23 (22%) 
Medication review 17 (16%) 
Birth control 12 (11%) 
Nutrition assessment 10 (9%) 
Epilepsy monitoring 8 (8%) 
Prescriptions 2.18 (2.50) 
Prescriptions   
Central nervous system 34 (32%) 
Cardiovascular system 19 (18%) 
Skin disorders 14 (13%) 
Respiratory system 12 (11%) 
 Endocrine system 11 (10%) 
Gastrointestinal system 11 (10%) 
Nutrition/blood 7 (7%) 
Ear, Nose and Throat 7 (7%) 
Obstetrics/gynaecology 6 (6%) 
Notes: Routine assessments and prescriptions less than 5% are not listed. 
Abbreviations: AHC=Annual Health Check; SD=standard deviation; N=number; GP=general practitioner
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Table 3. Mean (±SD) resource use per person per year before and after index date 
 
 
Resource use 
No Annual Health Check Annual Health Check 
N=102 N=106 
Before index 
date 
After index 
date 
Difference 
 
p-value Before index 
date 
After index 
date 
Difference 
 
p-value 
Primary care contacts 
GP (at general practice) 2.42 ± 3.89 4.00 ± 6.35 1.59    0.033 3.45 ± 3.41 4.10 ± 3.80  0.65  0.194 
Practice nurse (at general 
practice) 
0.54 ± 0.90 1.05 ± 1.88 0.51  0.015 1.45 ± 3.00 1.59 ± 2.15 0.14  0.698 
Community nurses (at general 
practice/clinic)  
0.03 ± 0.14 0.12 ± 0.32 0.08  0.018 0.05 ± 0.23 0.09 ± 0.30 0.04  0.308 
GP (phone) 0.58 ± 2.64 1.11 ± 3.18 0.53  0.199 0.55 ± 1.15 1.01 ± 1.51 0.46  0.014 
Practice nurse (phone) 0.28 ± 1.86 0.19 ± 0.81 -0.09  0.659 0.18 ± 0.46 0.35 ± 0.94 0.18  0.083 
Community nurses (phone) 0.04 ± 0.37 0.03 ± 0.24 -0.01  0.811 0.04 ± 0.36 0.02 ± 0.12 -0.02  0.588 
GP (home) 0.04 ± 0.15 0.10 ± 0.69  0.06    0.370 0.05 ± 0.20 0.15 ± 0.59 0.10   0.103 
Practice nurse (home) 0.01 ± 0.05 0.003 ± 0.03   -0.003   0.655 0.01 ± 0.09 0.03 ± 0.20 0.01  0.592 
Community nurses (home) 0.03 ± 0.29 0.23 ± 2.09 0.20  0.342 0.15 ± 1.56 0.03 ± 0.21 -0.12  0.433 
Community and secondary care activities 
Diagnostic procedures 0.23 ± 0.64 0.43 ± 1.00 0.20  0.085 0.42 ± 0.74 0.54 ± 0.94 0.11  0.332 
Laboratory tests 0.66 ± 1.21 1.06 ± 1.67 0.40  0.053 1.20 ± 1.60 1.58 ± 1.85 0.38   0.109 
Non-elective admissions 0.00 ± 0.00 0.06 ± 0.25 0.06  0.018 0.01 ± 0.05 0.01 ± 0.11 0.01  0.651 
Surgical procedures 0.04 ± 0.12 0.03 ± 0.10 -0.01  0.502 0.03 ± 0.17 0.04 ± 0.25 0.01   0.724 
Community healthcare services 
contacts 
0.09 ± 0.33 
 
0.24 ± 0.69 
 
0.15  
 
0.044 0.15 ± 0.54 
 
0.23 ± 0.61 
 
0.08  0.331 
Outpatient contacts 0.35 ± 1.02 0.94 ± 1.57 0.59  0.002 0.80 ± 1.22 1.95 ± 3.14 1.15  0.001 
Prescriptions 
Anaesthesia 0.00 ± 0.00 0.03 ± 0.22 0.03  0.151 0.02 ± 0.12 0.01 ± 0.08 -0.004  0.799 
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Borderline substances 0.13 ± 1.27 0.56 ± 3.82 0.44  0.272 0.00 ± 0.00 0.07 ± 0.49 0.07  0.167 
Cardiovascular system 2.55 ± 10.73 3.75 ± 11.29 1.20  0.437 11.41 ± 30.64 10.56 ± 29.35 -0.85  0.837 
Central nervous system 3.55 ± 8.02 6.88 ± 17.42 3.33  0.081 16.37 ± 42.30 17.87 ± 41.31 1.49  0.795 
Dental Formulary 0.00 ± 0.00 0.06 ± 0.51 0.06   0.237 0.00 ± 0.00 0.03 ± 0.32 0.03  0.319 
Ear, nose and throat 0.27 ± 1.35 0.38 ± 1.55 0.11  0.591 0.24 ± 0.62 0.34 ± 0.96 0.11  0.338 
Endocrine system 2.12 ± 9.85 2.87 ± 9.11 0.75  0.573 4.56 ± 13.63 4.07 ± 11.72 -0.50  0.777 
Eye 0.62 ± 4.13  0.21 ± 0.85 -0.41  0.330 0.55 ± 2.58 0.45 ± 1.64 -0.10  0.737 
Gastrointestinal system 0.84 ± 3.93 1.71 ± 5.04 0.87  0.173 5.22 ± 18.08 5.21 ± 16.93 -0.01  0.998 
Immune system 0.01 ± 0.04 0.02 ± 0.08 0.02  0.078 0.02 ± 0.14 0.11 ± 0.33 0.09  0.013 
Infections 0.53 ± 1.10 0.98 ± 3.25 0.45  0.182 1.35 ± 5.55 1.39 ± 4.96 0.05  0.950 
Malignant disease 0.03 ± 0.25 0.00 ± 0.00 -0.03  0.173 0.01 ± 0.12 0.00 ± 0.00 -0.01  0.319 
Muscular/ joint disease 0.30 ± 1.03 0.35 ± 0.96 0.04  0.765 1.07 ± 4.31 1.45 ± 10.33 0.38  0.730 
Nutrition/ blood products 0.58 ± 4.01 0.56 ± 2.59 -0.02  0.974 0.88 ± 3.19 2.68 ± 9.44 1.80  0.064 
Obstetrics/ gynaecology 0.65 ± 4.58 0.88 ± 4.39 0.23  0.712 1.48 ± 7.21 0.60 ± 2.35 -0.89   0.230 
Respiratory system 1.69 ± 8.34 2.58 ± 7.24 0.89  0.416 5.15 ± 29.76 2.06 ± 6.66 -3.09  0.298 
Skin disorder 0.62 ± 2.21 1.02 ± 3.00 0.39  0.289 1.77 ± 4.72 1.75 ± 3.32  -0.02  0.970 
Wound management 0.95 ± 8.66 0.78 ± 6.05 -0.17  0.873 0.11 ± 0.57 0.12 ± 0.55 0.01  0.935 
Abbreviations: N=number; GP=general practitioner; CI= confidence interval 
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Table 4. Mean (95% CI) healthcare costs per person per year before and after index date 
 No Annual Health Check Annual Health Check 
N=102 N=106 
Before index 
date 
After index 
date 
Difference 
 
p-value Before index 
date 
After index 
date 
Difference 
 
p-value 
Annual Health 
Check 
---- £142.57 
(£135.41 £149.74) 
Primary care 
contacts 
£126.54 
(£82.08; 
£170.99) 
£222.97 
(£154.85;  
£291.09) 
£96.43 
(£15.58; 
£177.29) 
0.020 £191.80 
(£147.01;  
£236.58) 
£232.09 
(£190.75;  
£273.43) 
£40.29 
(-£20.30; 
£100.89) 
0.191 
Community and 
secondary care 
activities 
£149.16 
(£87.31;  
£211.00) 
£306.94 
(£207.36;  
£406.53) 
£157.79 
(£41.27; 
£274.31) 
0.008 £253.65 
(£142.31;  
£364.99) 
£468.05 
(£189.83;  
£746.26) 
£214.40 
(-£83.53; 
£512.33) 
0.158 
Prescriptions £204.53 
(£42.20;  
£366.86) 
£248.89 
(£114.67;  
£383.11) 
£44.34 
(-£164.99; 
£253.73) 
0.677 £485.64 
(£131.98;  
£839.31) 
£311.03 
(£199.25;  
£422.81) 
-£174.61 
(-£543.37; 
£194.15) 
0.352 
Total cost £480.22 
(£258.58;   
£701.86) 
£778.81 
(£531.55; 
£1026.07) 
£298.59 
(-£31.47;  
£628.64) 
0.076 £931.09 
(£539.18; 
£1323.00) 
£1055.36 
(£731.31; 
£1379.41) 
£124.27 
(-£381.31; 
£629.86) 
0.629 
Abbreviations: N=number; CI=confidence interval 
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Table 5. Negative binomial regression model to examine the influence of AHC, age, 
gender and the total cost before index date on the healthcare costs per person with ID 
after index date (n=208) 
 IRR  (95%CI) 
Annual Health Check  1.5558 (1.1757; 2.0589) 
Female 1.5504 (1.1688; 2.0566) 
Age  1.0163 (1.0074; 1.0252) 
Cost before index date 1.0002 (1.0001; 1.0003) 
Notes: Dependent variable=total cost after the index date. Offset= exposure duration. Model=annual health check, 
age, gender and total cost before index date 
Abbreviations: IRR=incidence rate ratio; CI=confidence interval 
 
 
 
 
 
 
